Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluation of a mobile app for cardiac patient follow-up

Official title: Long-term Evaluation of a Mobile Application for Follow-up of Cardiac Patients

Run by University Hospital, Antwerp · NCT05951088 · Data updated 2026-11-12

This study tests a mobile app to see if it helps people with atrial fibrillation and heart failure manage their health better at home.

More Patient Education trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorUniversity Hospital, Antwerp
Academic / other
Locations1 site (Edegem, Antwerp)
StatusRecruiting
StartedMay 23, 2023
Main results expectedMay 30, 2026
Study endsMay 30, 2026
Registry record updatedMay 8, 2026
Trial IDNCT05951088 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older diagnosed with atrial fibrillation or heart failure who can provide informed consent.

Probably not a fit

Patients who cannot read or speak Dutch, have severe cognitive impairments, or do not own a smartphone or tablet may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates a mobile application designed to support patients with atrial fibrillation and heart failure in managing their conditions at home. The app provides educational resources, allows users to track health metrics, manage medications, and assess their quality of life through questionnaires. The study focuses on assessing the app's usability, long-term adherence, and patient satisfaction over time. By leveraging technology, the trial aims to enhance patient engagement and improve health outcomes.

Why it matters

Potential benefit: If successful, this app could significantly improve the management and quality of life for patients with atrial fibrillation and heart failure.

How similar studies have gone: Other studies have shown promise in using mobile health applications for chronic disease management, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years,
2. Patients in whom AF or atrial flutter is diagnosed with an electrocardiogram (12-lead, Holter monitor,…) and/or patients in whom HF is diagnosed in their medical records,
3. Patients who are capable of signing the informed consent.

Exclusion Criteria:

1. Not able to speak and read Dutch,
2. Cognitive impaired (e.g. severe dementia),
3. No smartphone or tablet available.

Where it's running

  • University Hospital Antwerp
    Edegem, Antwerp, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.